Skip to Content

Intradialytic Hypotension Tied to Peripheral Artery Disease

TUESDAY, Jan. 5, 2021 -- More frequent intradialytic hypotension (IDH) during hemodialysis is associated with a higher incidence of subsequent peripheral artery disease (PAD) diagnosis, according to a study published online Dec. 11 in the American Journal of Kidney Diseases.

Eun Young Seong, M.D., Ph.D., from the Pusan National University School of Medicine in Busan, South Korea, and colleagues used data linked from the U.S. Renal Data System to the electronic health records of a large dialysis provider to identify 45,591 adult patients with Medicare Parts A and B who initiated dialysis (2006 to 2011) without previously recognized PAD. Associations between IDH and newly diagnosed PAD were evaluated.

The researchers found that patients with more frequent baseline IDH had a higher prevalence of cardiovascular diseases. Newly recognized PAD was identified in 7,886 patients during 61,725 person-years of follow-up. There was a graded, direct association observed between IDH and newly recognized PAD; IDH in ≥30 percent of dialysis sessions during a 30-day interval was associated with a 24 percent higher risk for newly recognized PAD in the subsequent 30 days compared with patients with no sessions with IDH.

"Our results suggest that patients with more frequent IDH warrant careful examination for PAD such as foot examinations or other diagnostic evaluations," the authors write.

Two authors disclosed financial ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

© 2021 HealthDay. All rights reserved.

Posted: January 2021

Read this next

Intensive Therapy for HTN Tied to Drop in Orthostatic Hypotension

TUESDAY, Sept. 15, 2020 -- Intensive blood pressure (BP)-lowering treatment in adults with hypertension is associated with a reduced likelihood of orthostatic hypotension (OH),...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.